Mediator kinase inhibition reverses castration resistance of advanced prostate cancer
Mediator kinases CDK19 and CDK8, pleiotropic regulators of transcriptional reprogramming,
are differentially regulated by androgen signaling, but both kinases are upregulated in …
are differentially regulated by androgen signaling, but both kinases are upregulated in …
Kinase Drug Discovery: Impact of Open Science and Artificial Intelligence
F Miljković, J Bajorath - Molecular Pharmaceutics, 2024 - ACS Publications
Given their central role in signal transduction, protein kinases (PKs) were first implicated in
cancer development, caused by aberrant intracellular signaling events. Since then, PKs …
cancer development, caused by aberrant intracellular signaling events. Since then, PKs …
Unveiling the impact of CDK8 on tumor progression: mechanisms and therapeutic strategies
X Yin, Z He, K Chen, K Ouyang, C Yang, J Li… - Frontiers in …, 2024 - frontiersin.org
CDK8 is an important member of the cyclin-dependent kinase family associated with
transcription and acts as a key “molecular switch” in the Mediator complex. CDK8 regulates …
transcription and acts as a key “molecular switch” in the Mediator complex. CDK8 regulates …
Preclinical therapeutic efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR inhibition in Neuroblastoma
S Stauffer, JS Roth, ER Hernandez, JT Kowalczyk… - Cancers, 2024 - mdpi.com
Simple Summary The prognosis for patients with relapsed neuroblastoma is poor, and novel
treatment options for these patients are needed. Some relapsed neuroblastoma tumors …
treatment options for these patients are needed. Some relapsed neuroblastoma tumors …
Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor suppression by mTOR and AKT inhibitors
Triple-negative breast cancers (TNBC) are treated primarily by chemotherapy and lack
clinically validated therapeutic targets. In particular, inhibitors of the PI3K/AKT/mTOR …
clinically validated therapeutic targets. In particular, inhibitors of the PI3K/AKT/mTOR …
Integrating multi-omics data reveals neuroblastoma subtypes in the tumor microenvironment
J Fan, S Tang, X Kong, Y Cun - Life Sciences, 2024 - Elsevier
Neuroblastoma (NB) is a severe pediatric tumor originating from the developing sympathetic
nervous system, characterized by diverse clinical outcomes, including spontaneous …
nervous system, characterized by diverse clinical outcomes, including spontaneous …
CDK19 and CDK8 Mediator kinases drive androgen-independent in vivo growth of castration-resistant prostate cancer
Castration-resistant prostate cancer (CRPC) remains incurable due to its high plasticity. We
found that Mediator kinases CDK8 and CDK19, pleiotropic regulators of transcriptional …
found that Mediator kinases CDK8 and CDK19, pleiotropic regulators of transcriptional …
Inhibition of Cyclin-Dependent Kinases 8/19 Restricts Bacterial and Virus-Induced Inflammatory Responses in Monocytes
EK Kokinos, SA Tsymbal, AV Galochkina… - Viruses, 2023 - mdpi.com
Hyperactivation of the immune system remains a dramatic, life-threatening complication of
viral and bacterial infections, particularly during pneumonia. Therapeutic approaches to …
viral and bacterial infections, particularly during pneumonia. Therapeutic approaches to …
CRISPR-Cas System Is an Effective Tool for Identifying Drug Combinations That Provide Synergistic Therapeutic Potential in Cancers
Y Kim, HM Lee - Cells, 2023 - mdpi.com
Despite numerous efforts, the therapeutic advancement for neuroblastoma and other cancer
treatments is still ongoing due to multiple challenges, such as the increasing prevalence of …
treatments is still ongoing due to multiple challenges, such as the increasing prevalence of …
[PDF][PDF] Inhibition of Cyclin-Dependent Kinases 8/19 Restricts Bacterial and Virus-Induced Inflammatory Responses in Monocytes. Viruses 2023, 15, 1292
EK Kokinos, SA Tsymbal, AV Galochkina… - 2023 - academia.edu
Hyperactivation of the immune system remains a dramatic, life-threatening complication of
viral and bacterial infections, particularly during pneumonia. Therapeutic approaches to …
viral and bacterial infections, particularly during pneumonia. Therapeutic approaches to …